Cure Sanfilippo Foundation Chief Science Officer and Co-Founder Cara O’Neill, MD, FAAP, will be a speaker at American Society of Gene-Cell Therapy’s (ASGCT) Empowering Patients 2025: A Cell and Gene Therapies Summit in March.
O’Neill will join Terry Flotte, MD, University of Massachusetts for the “When Innovation Stumbles and Pathways Forward” session on March 12. The session will explore the state of commercially pre-viable therapies (sometimes referred to as “dropped” or “discontinued” trials). O’Neill will offer the perspective of a patient advocate on why this happens and potential solutions.
The Empowering Patients 2025 summit is an inaugural digital event, March 12 & 13, 2025, to provide timely education and engaging discussions on cell and gene therapies (CGTs). In alignment with ASGCT’s strategic plan, the goal is to empower advocates, patients, and caregivers who are vital in developing treatments. Attendees will hear from experts in the CGT field, as well as patient advocacy group leaders. There will be opportunities to ask questions and deepen your knowledge of the community’s CGT journey.
Registration for ASGCT’s Empowering Patients 2025 is free. See the full agenda and/or register.